Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study.
Lepor NE, Sun J, Canton G, Contreras L, Hippe DS, Isquith DA, Balu N, Kedan I, Simonini AA, Yuan C, Hatsukami TS, Zhao XQ.
Lepor NE, et al. Among authors: kedan i.
Atherosclerosis. 2021 Jun;327:31-38. doi: 10.1016/j.atherosclerosis.2021.05.008. Epub 2021 May 19.
Atherosclerosis. 2021.
PMID: 34038761